Titan Medical Inc. officials have signed a research agreement with Vanderbilt University. The agreement is for the testing and evaluation of the company's Insertable Robotic Effector Platform (IREP) in conjunction with the Advanced Robotics and Mechanism Applications Research Laboratory (ARMA Lab) headed by Dr. Nabil Simaan, associate professor of mechanical engineering who is affiliated with the newly established Vanderbilt Initiative in Surgery and Engineering (VISE) at Vanderbilt University.
Under the terms of the agreement, ARMA lab will perform testing of the IREP, which include exploratory, workspace, engineering, and tissue testing over an eight-week period. The results and evaluation of the IREP will layout the development and clinical plans necessary for regulatory submission and commercialization of the IREP.
"Advancing the development of the IREP is a crucial step for the Company in its quest to provide next generation robotic surgical solutions for all hospital tiers worldwide," states Craig Leon, CEO of Titan Medical Inc. "We are dedicated to advancing the clinical development of the IREP and realizing its value as a next generation robotic surgery solution for single port access surgery, which is currently an underserved and large market opportunity for the company."
Latest from Today's Medical Developments
- GrindingHub Americas launches in 2027 in Cincinnati, Ohio
- Methods Machine Tools now offers the Nakamura-Tome NT-Flex
- Battelle awards $900,000 in STEM education grants to Ohio schools
- #55 Lunch + Learn Podcast with KINEXON
- Starrett and Gerstner offer limited edition, American made 1950s replica wooden machinist tool chests
- EMCO’s UNIVERSALTURN 50: The new benchmark in universal turning
- Archetype's Expertise for Equity accelerates early-stage innovation
- Stratasys expands its AM solutions with Tritone's cutting-edge technology
